14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $50.35 $57.15 Thursday, 2nd May 2024 INCY stock ended at $53.09. This is 0.283% more than the trading day before Wednesday, 1st May 2024. During the day the stock fluctuated 2.26% from a day low at $52.28 to a day high of $53.46.
90 days $50.35 $61.87
52 weeks $50.27 $67.72

Historical Incyte Corporation prices

Date Open High Low Close Volume
Aug 22, 2023 $64.83 $65.55 $64.46 $64.79 1 171 837
Aug 21, 2023 $64.04 $65.02 $63.67 $64.88 1 295 828
Aug 18, 2023 $63.78 $64.53 $63.58 $64.04 790 256
Aug 17, 2023 $64.79 $65.02 $64.13 $64.21 1 822 131
Aug 16, 2023 $65.19 $65.63 $64.63 $64.73 1 014 395
Aug 15, 2023 $64.91 $65.70 $64.77 $65.41 767 975
Aug 14, 2023 $65.71 $66.15 $65.11 $65.24 2 231 148
Aug 11, 2023 $65.73 $66.24 $65.45 $65.93 1 015 190
Aug 10, 2023 $65.66 $66.44 $65.27 $65.51 1 637 846
Aug 09, 2023 $64.58 $65.93 $64.56 $65.42 1 309 121
Aug 08, 2023 $65.27 $65.54 $64.26 $64.53 1 098 601
Aug 07, 2023 $63.79 $65.20 $63.57 $64.91 1 525 857
Aug 04, 2023 $64.46 $65.10 $63.58 $63.63 1 205 501
Aug 03, 2023 $65.72 $65.83 $64.97 $64.98 1 264 773
Aug 02, 2023 $63.79 $65.98 $63.79 $65.68 2 041 095
Aug 01, 2023 $65.47 $65.76 $62.21 $63.69 2 444 433
Jul 31, 2023 $63.07 $63.95 $62.90 $63.72 2 059 628
Jul 28, 2023 $63.15 $63.25 $62.50 $63.09 1 165 856
Jul 27, 2023 $62.77 $63.35 $62.52 $62.68 1 277 004
Jul 26, 2023 $63.80 $63.80 $62.53 $62.80 1 409 354
Jul 25, 2023 $63.94 $64.38 $63.62 $63.79 1 278 922
Jul 24, 2023 $64.26 $64.50 $63.32 $63.46 945 577
Jul 21, 2023 $64.17 $64.39 $63.49 $64.15 1 663 852
Jul 20, 2023 $63.30 $64.03 $63.11 $64.01 1 529 732
Jul 19, 2023 $62.26 $62.94 $62.07 $62.90 1 501 976
Click to get the best stock tips daily for free!

About Incyte Corporation

Incyte Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as oncogenic drivers in various liquid and solid tumor types; and ICLUSIG, a kinase inhibitor to treat chr... INCY Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT